BRTX BioRestorative Therapies, Inc.

NASDAQ
$0.15

BioRestorative Therapies, Inc. (BRTX) SEC Filings

Everything BRTX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

5 filings
Date Form Filing
8-K Governance Change · Other · Reg Fd
8-K Auditor Change · Executive Change
8-K Delisting
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.